tafamidis
-
Pfizer’s tafamidis drug reduced the risk of death for patients with rare heart disease by 30 percent
Aug 28, 2018Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 percent, boosting the prospects of what could be a billion-dollar-a-year...